	NK cells in breast cancer. Trends Immunol Massidda A, Moragon-Terencio S, de Chanville CB, André F, Vivier E, Narni-Mancinelli E. PMID: 42595581 [PubMed - as supplied by publisher]
	Clinical Trial Protocol for LPS-Boost: Intensified [(177)Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease. J Nucl Med Iravani A, Gulati R, Miyaoka R, Reiger AC, Chen DL, Kumar M, Erickson M, Nega K, Meyer C, Lira S, Seo Y, Flavell RR, Pritchard CC, Haffner MC, Nadal Rios R, Sunkara R, Khan HM, Yezefski T, Raychaudhuri R, Hsieh AC, Grivas P, Cheng HH, Yu EY, Schweizer MT, Nelson PS, Czernin J, Hope TA, Calais J. PMID: 42595485 [PubMed - as supplied by publisher]
	Cryoablation versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia Mao K, Wang Y, Yao W, Ding J, Ye Z, Ye Y, Zhu R. PMID: 42595456 [PubMed - indexed for MEDLINE]
	Solitary fibrous tumour mimicking a urethral caruncle: a diagnostic pitfall. BMJ Case Rep Ono Y, Miyazawa Y, Arai S, Sekine Y, Sugita K. PMID: 42595384 [PubMed - indexed for MEDLINE]
	Intraplacental Choriocarcinoma Presenting With Postpartum Hemorrhage Requiring Uterine Artery Embolization: A Case Report. J Obstet Gynaecol Res Tsuge S, Yoshida K, Shirasaki M, Nakamura H, Niimi K, Kajiyama H. PMID: 42595378 [PubMed - indexed for MEDLINE]
	Clinical profile and quality of life in late-onset and very-late-onset myasthenia gravis: a cross-sectional study. Arq Neuropsiquiatr da Silva AFF, Kay CSK, Ducci RD, Rodrigues PRDVP, Fustes OJH, Lorenzoni PJ, Scola RH. PMID: 42595322 [PubMed - indexed for MEDLINE]
	Targeting the Ubiquitin-Proteasome System: An Emerging Paradigm for Overcoming Resistance to Targeted Therapy in Non-Small Cell Lung Cancer. Exp Cell Res Chen R, Zhu H, Zhou K, Xie J. PMID: 42595292 [PubMed - as supplied by publisher]
	Comparing Different Planning Strategies for Pencil Beam Scanning Carbon Ion Radiotherapy for Stage I Peripheral Non-Small Lung Cancer: Toward Optimized Clinical Decision-Making. Int J Radiat Oncol Biol Phys Lu Y, Chen J, Sheng Y, Wang W, Mao J. PMID: 42595262 [PubMed - as supplied by publisher]
	Dosimetric parameters of the axillary-lateral thoracic junction in predicting risk of breast cancer-related lymphedema. Radiother Oncol Hong SW, Kim EK, Shin HC, Beom J, Lim JY, Kim IA, Kim K. PMID: 42595256 [PubMed - as supplied by publisher]
	Pediatric Urologic Oncology Series: Surgeon Focused Update of the Changes to the New Children's Oncology Group Study of Unilateral Favorable Histology Wilms Tumor (AREN2231). Urology Spencer K, Peard L, Romao R, Kieran K, Cost N, Buchanan A. PMID: 42595231 [PubMed - as supplied by publisher]
	ZEB1 orchestrates cellular plasticity and therapy resistance in prostate cancer: from molecular mechanisms to clinical targeting. Crit Rev Oncol Hematol Wang Q, Wang J, Zhao Y, Yan J, Zhang Y, Liu Z, Zhao Z, Yu H. PMID: 42595197 [PubMed - as supplied by publisher]
	Modern Therapies: Nanotechnology Promises New Approaches for Rare Breast Cancer to Brain Metastases. SLAS Discov Muteeb G, El-Sayed AY, AboHoussien MS, Abuelnile RH, Shaaban AH, Jaafari JIA, Kumari S, Farhan M, Aatif M, Khafaga DSR. PMID: 42595178 [PubMed - as supplied by publisher]
	Coupling redox regulation with Cancer immunotherapy: The challenge of polyphenol Nanocarriers. Adv Drug Deliv Rev Curcio M, Saletta F, Scorzafave L, Fiore M, Nicoletta FP, Iemma F, Vittorio O, Cirillo G. PMID: 42595127 [PubMed - as supplied by publisher]
	Systemic Treatment Patterns and Clinical Outcomes in Hepatocellular Carcinoma: A Multicenter Real-World Study from China (STAR-HCC). JHEP Rep He B, Liao W, Zheng Z, Gan J, Zuo Z, Deng M, Lai F, Zhong C, Luo R, Guan R, Tang M, Lu L, Wen Y, Li S, Zhao R, Mei J, Guo R, Wei W. PMID: 42595051 [PubMed - as supplied by publisher]
	Management of rare primary liver cancers: combined hepato-cholangiocarcinoma and fibrolamellar hepatocellular carcinoma. JHEP Rep Gallant M, Decraecker M, Ziol M, Calderaro J, Ronot M, Zucman-Rossi J, Nault JC. PMID: 42595050 [PubMed - as supplied by publisher]
	Aryl Hydrocarbon Receptor Activation by Imidacloprid as a Promoter of HER2(+) Breast Cancer Progression: In silico, in vitro and in vivo studies. Environ Res Buján S, Miret N, Torres D, Pontillo C, Chiappini F, Nicola Candia A, Agustina L, Sofia MM, Bressan M, Scicolone G, Candolfi M, Randi A. PMID: 42595034 [PubMed - as supplied by publisher]
	Emotional Freedom Techniques for cancer-related sleep disturbance and associated symptoms: A systematic review and meta-analysis. Complement Ther Med Xu H, Soh KL, Yubbu PB, Soh KG. PMID: 42595020 [PubMed - as supplied by publisher]
	Senescence-Associated Mitochondrial Dysfunction as a Therapeutic Target in Ovarian Cancer: Challenges and Opportunities. Eur J Pharmacol Khalili HS, Abadi B, Rezaei N. PMID: 42594984 [PubMed - as supplied by publisher]
	Drug resistance in breast cancer brain metastasis: mechanisms and therapeutic strategies. Biochim Biophys Acta Rev Cancer Sarker P, Rao SS. PMID: 42594975 [PubMed - as supplied by publisher]
	Real-World Perioperative and Early Oncological Outcomes of Robot-Assisted Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Single-Institution Series of 100 Consecutive Patients. Asian J Endosc Surg Yajima S, Okumura G, Gozu S, Kataoka M, Nakanishi Y, Masuda H. PMID: 42594915 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 1963800

Page 1 of 98190



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy